Research on HBV DNA inhibition of plasmid acute infection mouse with betulinic acid.
- Author:
Bing QIAO
;
Yue-Qiu GAO
;
Man LI
;
Shao-Fei WU
;
Chao ZHENG
;
Shu-Gen JIN
;
Hui-Chun WU
;
Zhuo YU
;
Xue-Hua SUN
- Publication Type:Journal Article
- MeSH:
Acute Disease;
Animals;
Antiviral Agents;
pharmacology;
DNA Replication;
drug effects;
DNA, Viral;
biosynthesis;
Hepatitis B;
blood;
virology;
Hepatitis B Surface Antigens;
blood;
Hepatitis B virus;
drug effects;
genetics;
immunology;
physiology;
Male;
Mice;
Plasmids;
genetics;
Triterpenes;
pharmacology;
Virus Replication;
drug effects
- From:
China Journal of Chinese Materia Medica
2014;39(6):1097-1100
- CountryChina
- Language:Chinese
-
Abstract:
Betulinic acid is a naturally occurring pentacyclic triterpenoid, which has antiretroviral, antimalarial, and anti-inflammatory properties. The purpose of this study is to investigate the HBV DNA replication inhibition in the mouse model with betulinic acid. Hydrodynamic injection method via the tail vein with the Paywl. 3 plasmid was used to establish the animal mode (n = 15), and the mice were randomly divided into the PBS control group (n = 5), Betulinic acid treatment group (n = 5) and lamivudine control group (n = 5). The day after successful modeling , the mice would have taken Betulinic acid (100 mg x kg(-1)), lamivudine (50 mg x kg(-1)), PBS drugs orally, once daily for 7 days, blood samples were acquired from the orbital venous blood at 3, 5, 7 days after the administering, HBsAg and HBeAg in serum concentration were measured by ELISA and the mice were sacrificed after 7 days, HBV DNA southern detections were used with part of mice livers. The results showed that betulinic acid significantly inhibited the expression of HbsAg in the mice model at the fifth day compared with the control group, and there was no significant differences between the effects of lamivudine and the PBS control group; both the betulinic acid and lamivudine groups had no significant inhibition for the HBeAg expression; the HBV DNA expressions of the liver tissue from the betulinic acid and lamivudine groups were inhibited compared with the control group. Taken together, these results reveal betulinic acid can inhibit the HBsAg expression and replication of the liver HBV DNA in the mouse model.
